Patents by Inventor Christianus Jacobus van Platerink

Christianus Jacobus van Platerink has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8618249
    Abstract: Use of the tripeptide ITP and salts thereof for the preparation of a functional food angiotensin-converting enzyme inhibitor. Also provided is the use of the combination of tripeptide MAP and the tripeptide ITP and salts thereof as an angiotensin-converting enzyme inhibitor in functional foods.
    Type: Grant
    Filed: July 8, 2011
    Date of Patent: December 31, 2013
    Assignee: DSM IP Assets B.V.
    Inventor: Christianus Jacobus van Platerink
  • Publication number: 20110263506
    Abstract: Use of the tripeptide ITP and salts thereof for the preparation of a functional food angiotensin-converting enzyme inhibitor. Also provided is the use of the combination of tripeptide MAP and the tripeptide ITP and salts thereof as an angiotensin-converting enzyme inhibitor in functional foods.
    Type: Application
    Filed: July 8, 2011
    Publication date: October 27, 2011
    Applicant: CONOPCO, INC. D/B/A UNILEVER
    Inventor: Christianus Jacobus van Platerink
  • Publication number: 20090325888
    Abstract: The present invention provides the tripeptide MAP and/or the tripeptide ITP and/or salts thereof for use as a health benefit agent, especially in functional food products. The tripeptides have particular application in the areas of the prevention of obesity or body weight control and cardiovascular health maintenance, especially the inhibition of angiotensin-converting enzyme and the control of blood cholesterol levels. Functional Food products comprising these tripeptides and having health benefits in these areas, and a process for making these products, are also provided. The tripeptides can be conveniently incorporated into food products to provide the aforementioned health benefits to the consumer thereof.
    Type: Application
    Filed: March 31, 2006
    Publication date: December 31, 2009
    Inventors: Luppo Edens, Cinderella Christina Gerhardt, Christianus Jacobus Van Platerink, Andre Leonardus De Roos
  • Publication number: 20090312270
    Abstract: Use of the tripeptide MAP optionally in combination with tripeptide ITP and salts thereof for the preparation of a functional food angiotensin-converting enzyme inhibitor. Also provided is the use of the tripeptide MAP and optionally the tripeptide ITP or salts thereof as an angiotensin-converting enzyme inhibitor in functional foods.
    Type: Application
    Filed: March 31, 2006
    Publication date: December 17, 2009
    Inventor: Christianus Jacobus Van Platerink
  • Publication number: 20090304869
    Abstract: Use of the tripeptide ITP and salts thereof for the preparation of a functional food angiotensin-converting enzyme inhibitor. Also provided is the use of the combination of tripeptide MAP and the tripeptide ITP and salts thereof as an angiotensin-converting enzyme inhibitor in functional foods.
    Type: Application
    Filed: March 31, 2006
    Publication date: December 10, 2009
    Inventor: Christianus Jacobus van Platerink
  • Publication number: 20090143311
    Abstract: The present invention describes the use of MAP and/or ITP or a salt thereof as a nutraceutical, preferably a medicament.
    Type: Application
    Filed: March 31, 2006
    Publication date: June 4, 2009
    Inventors: Luppo Edens, Cinderella Christina Gerhardt, Christianus Jacobus Van Platerink, Swen Wolfram
  • Publication number: 20090131331
    Abstract: The present invention describes the use of MAP and/or ITP or a salt thereof as a nutraceutical, preferably a medicament.
    Type: Application
    Filed: April 27, 2006
    Publication date: May 21, 2009
    Applicant: DSM IP ASSETS B.V.
    Inventors: Luppo Edens, Swen Wolfram, Christianus Jacobus Van Platerink, Cinderella Christina Gerhardt
  • Publication number: 20020182301
    Abstract: A Fermented milk product is described having an ACE inhibitory effect of at least 35 U/ml, wherein the milk product is produced from milk fermented with Lactobacillus delbrueckii subsp. lactis. Further a food product is described comprising an amount of 0.003 mg/g protein, or more a peptide or peptide salt having 2-15 amino acids, comprising the peptide sequence Asp-Lys and/or Ile-His-Pro-Phe.
    Type: Application
    Filed: March 8, 2002
    Publication date: December 5, 2002
    Applicant: Unilever Bestfoods North America, Division of Conopco, Inc.
    Inventors: Rene Draaisma, Mettina Maria Koning, Adrianus Marinus Ledeboer, Elisabeth Claire Leigh-Firbank, Christianus Jacobus Van Platerink, Johannes Schalk